4
Changes in Ownership
Werewolf Therapeutics, Inc. Filed Acc 0001231919-25-000533
10% owner sold 160,103 shares at an average $0.92 ($147,913)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| GADICKE ANSBERT 10% owner | 2025-11-18 | Sale 10b5-1 | −52,627 | $0.93 | $48,943 | 5,428,912 | I |
| GADICKE ANSBERT 10% owner | 2025-11-19 | Sale 10b5-1 | −66,324 | $0.94 | $62,345 | 5,362,588 | I |
| GADICKE ANSBERT 10% owner | 2025-11-20 | Sale 10b5-1 | −41,152 | $0.89 | $36,625 | 5,321,436 | I |
| Open-market sales · 160,103 sh · avg $0.92 · $147,913 | |||||||
Loading xslF345X05/form4-11202025_101121.xml…